维克斯特罗尔B通过核因子-κB (NF-κB) 途径重新激活潜伏的人类免疫缺陷病毒 (HIV-1)
Ziyao Wu1, Kang Ding2, Wenli Liu1
1Key Laboratory of Infectious Diseases Research in South China, Ministry of Education, NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, PR China.
概括
维克斯特罗尔B是一种新型的黄类化合物,可重新激活潜伏的HIV-1并抑制病毒感染,毒性较低. 这种化合物在与现有疗法相结合时,对HIV-1治愈策略有前途.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 目前的HIV-1治疗方法,如联合抗逆转录病毒疗法 (cART),受到潜伏病毒储备的限制.
- 现有的延迟逆转剂 (LRAs) 经常表现出不足的疗效和不良副作用.
- 开发具有高抗病毒活性和低细胞毒性的LRA对于功能性HIV-1治愈至关重要.
研究的目的:
- 为了确定具有双重活性的黄类药物:重新激活潜伏的HIV-1并抑制病毒复制.
- 阐明这些双重行动的基本机制.
主要方法:
- 从Stellera chamaejasme中选21种黄类物质,识别维克斯特罗尔B.
- 使用ELISA,RT-qPCR和流式细胞计量来评估潜伏的HIV-1活性.
- 通过MTT试验评估细胞毒性,并使用WB,共聚焦显微镜和ChIP试验探索机制.
- 通过ELISA和Co-IP分别研究抗HIV-1活性和Vif/hA3G复杂相互作用.
主要成果:
- 维克斯特罗B在低微分子度下有效地逆转了细胞系和初级CD4+T细胞中的HIV-1潜伏,细胞毒性最小.
- 该机制涉及通过NF-κB通路调节对HIV-1长终端重复 (LTR) 交换激活的特定诱导.
- 通过阻断Vif介导的降解,证明了HIV-1IIIB的强烈抑制.
结论:
- 维克斯特罗尔B具有双重能力:重新激活潜伏的HIV-1和抑制病毒感染,具有有利的安全性.
- 维克斯特罗B具有"震惊并杀死"HIV-1治疗策略的潜力,特别是在与cART和其他LRA的协同组合中.
相关概念视频
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
Co-activators and Co-repressors
7.2K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.2K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Retroviruses
12.1K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.1K
Eukaryotic Transcription Inhibitors
9.7K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.7K
B Cell Activation and Differentiation
1.2K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.2K


